eicosanoids signaling molecules made enzymatic nonenzymatic oxidation arachidonic acid polyunsaturated fatty acids pufas similar arachidonic acid around carbon units length eicosanoids subcategory oxylipins ie oxidized fatty acids diverse carbon units length distinguished oxylipins overwhelming importance cell signaling molecules eicosanoids function diverse physiological systems pathological processes mounting inhibiting inflammation allergy fever immune responses regulating abortion pregnancy normal childbirth contributing perception pain regulating cell growth controlling blood pressure modulating regional flow blood tissues performing roles eicosanoids often act autocrine signaling agents impact cells origin paracrine signaling agents impact cells proximity cells origin eicosanoids may also act endocrine agents control function distant cells multiple subfamilies eicosanoids including prominently prostaglandins thromboxanes leukotrienes lipoxins resolvins eoxins subfamily potential least separate series metabolites two series derived pufas arachidonic dihomogammalinolenic acids one series derived pufa eicosapentaenoic acid one series derived pufa mead acid subfamily distinction important mammals including humans unable convert pufa consequence tissue levels pufas corresponding eicosanoid metabolites link directly amount dietary versus pufas since certain pufa series metabolites almost diametrically opposing physiological pathological activities often suggested deleterious consequences associated consumption pufarich diets reflects excessive production activities pufaderived eicosanoids beneficial effects associated consumption pufarich diets reflect excessive production activities pufaderived view opposing effects pufaderived pufaderived eicosanoids key target cells underlie detrimental beneficial effects pufarich diets inflammation allergy reactions atherosclerosis hypertension cancer growth host processes eicosanoid eicosa greek twenty see icosahedron collective straightchain polyunsaturated fatty acids pufas carbon units length metabolized otherwise converted oxygencontaining products pufa precursors eicosanoids include particular eicosanoid denoted fourcharacter abbreviation composed stereochemistry eicosanoid products formed may differ among pathways prostaglandins often indicated greek letters eg versus hydroperoxy hydroxy eicosanoids r designates chirality substituents eg acid also termed acid given trivial names since eicosanoidforming enzymes commonly make isomer products either marked preference essentially exclusively use sr designations often dropped eg nonetheless certain eicosanoidforming pathways form r isomers versus r isomeric products exhibit dramatically different biological failing specify sr isomers misleading hydroperoxy hydroxy substituents configuration unless noted otherwise current usage limits term eicosanoid hydroxyeicosatetraenoic acids leukotrienes eoxins prostanoids sometimes termed classic contrast classic eicosanoids several classes pufa metabolites termed novel eicosanoidlike nonclassic included following classes metabolism eicosapentaenoic acid hepes leukotrienes prostanoids epoxyeicosatetraenoic acids well metabolism dihomogammalinolenic acid prostanoids mead acid acid acid involve enzymatic pathways make arachidonic acidderived analogs eicosanoids typically stored within cells rather synthesized required derive fatty acids make cell membrane nuclear membrane fatty acids must released membrane sites metabolized initially products often metabolized various pathways make large array products recognize bioactive eicosanoids eicosanoid biosynthesis begins cell activated mechanical trauma ischemia physical perturbations attack pathogens stimuli made nearby cells tissues pathogens chemotactic factors cytokines growth factors even certain eicosanoids activated cells mobilize enzymes termed phospholipase capable releasing fatty acids membrane storage fatty acids bound ester linkage position membrane phospholipids act esterases release fatty acid several classes type iv cytosolic appearing responsible releasing fatty acids many conditions cell activation act specifically phospholipids contain aa epa gpla position may also release lysophospholipid becomes plateletactivating next free fatty acid oxygenated along several pathways see pathways table eicosanoid pathways via lipoxygenase cox add molecular oxygen although fatty acid symmetric resulting eicosanoids chiral oxidations proceed high stereoselectivity enzymatic oxidations considered practically stereospecific four families enzymes initiate contribute initiation catalysis fatty acids eicosanoids two different enzymes may act series pufa form complex metabolites example acts aspirintreated metabolize arachidonic acid lipoxins cytochrome monooxygenases bacterial cytochrome infected tissues aspirintreated metabolize eicosapentaenoic acid e series resolvins rves see specialized proresolving mediators occurs enzymes located different cell types involves transfer one enzymes product cell uses second enzyme make final product referred transcellular metabolism transcellular oxidation lipids hazardous cells particularly close nucleus elaborate mechanisms prevent unwanted oxidation cox lipoxygenases phospholipases tightly least eight proteins activated coordinate generation leukotrienes several exist multiple oxidation either cox lipoxygenase releases reactive oxygen species ros initial products eicosanoid generation highly reactive peroxides form adducts tissue dna reactions lipoxygenases generate cellular damage murine models implicate pathogenesis oxidation eicosanoid generation compartmentalized limits peroxides damage enzymes biosynthetic eicosanoids eg glutathionestransferases epoxide hydrolases carrier proteins belong families whose functions involved largely cellular detoxification suggests eicosanoid signaling might evolved detoxification ros cell must realize benefit generating lipid hydroperoxides closeby nucleus pgs lts may signal regulate dnatranscription ligand see diagram ppar also termed prostaglandinendoperoxide respectively metabolize arachidonic acid adding molecular carbons form endoperoxide bridge two carbons adding molecular carbon yield product creating carboncarbon bond carbons create cyclopentane ring middle fatty acid process making product two fewer double bonds arachidonic acid residue reduced residue thereby forming parent prostanoid prostanoids metabolized see diagram prostanoid prostaglandin e synthase pathway one three isozymes ptges convert subsequent products pathway include see prostanoid biosynthesis prostaglandins b pgf synthase converts c prostaglandin synthase converts subsequent products pathway include see cyclopentenone prostaglandin thromboxane synthase converts subsequent products pathway include e prostacyclin synthase converts subsequent products pathway include pathways shown cases presumed metabolize eicosapentaenoic acid eicosanoid analogs sited products three rather two double bonds therefore contain number place attached names eg instead products formed pathways cited undergo spontaneous dehydration reaction form respectively may undergo spontaneous isomerization followed dehydration reaction form series ring bridged molecular oxygen derived pgs lost oxygen bridge contain single unsaturated ring exception thromboxane possesses ring consisting one oxygen carbon atoms ring prostacyclin conjoined second ring consisting carbon one oxygen atom member ring cyclopentenone prostaglandins possesses unsaturated bond conjugated system carbonyl group causes pgs form bonds diverse range bioactive proteins see diagrams prostanoid enzyme converts arachidonic acid acid may released rapidly reduced acid ubiquitous cellular glutathionedependent alternately uses lta synthase activity act convert leukotriene metabolized either leukotriene hydrolase leukotriene either synthase microsomal glutathione stransferase either latter two enzymes act attach sulfur cysteines thio ie sh group tripeptide glutamatecysteineglycine carbon thereby forming release parent cell glutamate glycine residues removed stepwise gammaglutamyltransferase dipeptidase form sequentially decision form versus depends relative content hydrolase versus synthase glutathione stransferase cells eosinophils mast cells alveolar macrophages possess relatively high levels synthase accordingly form rather far greater extent may also work series cytochrome oxygenases aspirintreated form resolvins see specialized proresolving mediators epaderived resolvins enzyme arachidonate metabolizes arachidonic acid stereoisomer acid rapidly reduced cellular peroxidases stereoisomer acid metabolized hepoxilins hx enzymes metabolize arachidonic acid stereoisomer acid rapidly reduced cellular peroxidases stereoisomer acid particularly may also act series aspirintreated form lipoxins epilipoxins oxygenases aspirintreated form resolvin see specialized proresolving mediators epaderived resolvins subset cytochrome microsomebound ωhydroxylases metabolize arachidonic acid acid acid omega oxidation human cytochrome cyp epoxygenases metabolize arachidonic acid nonclassic epoxyeicosatrienoic acids eets converting one fatty acids double bonds epoxide form one following eets major eets produced mammalian including human cyps also metabolize eicosapentaenoic acid five epoxide epoxyeicosatetraenoic acids eeqs viz following table lists sampling major eicosanoids possess clinically relevant biological activity cellular receptors see cell surface receptor stimulate noted antagonize attain activity major functions regulate either promote inhibit humans mouse models relevancies human diseases many prostanoids known mediate local symptoms inflammation vasoconstriction vasodilation coagulation pain fever inhibition andor inducible isoforms hallmark nsaids nonsteroidal antiinflammatory drugs aspirin prostanoids also activate pparγ members steroidthyroid family nuclear hormone receptors directly influence gene prostanoids numerous relevancies clinical medicine evidence use use stable pharmacological analogs use receptor antagonists indicated following chart exhibit wide range antiinflammatory inflammationresolving actions diverse animal therefore appear function manner similar specialized proresolving mediators although one mechanisms action forming covalent bonds key signaling proteins differs specialized proresolving mediators indicated individual wikipedia pages acid like acid acts receptor acid acid acid acid show numerous activities animal human cells well animal models related example inflammation allergic reactions cancer cell growth blood flow tissues andor blood pressure however function relevancy human physiology pathology yet shown three cysteinyl leukotrienes potent bronchoconstrictors increasers vascular permeability postcapillary venules stimulators mucus secretion released lung tissue asthmatic subjects exposed specific allergens play pathophysiological role diverse types immediate hypersensitivity drugs block activation receptor viz montelukast zafirlukast pranlukast used clinically maintenance treatment allergeninduced asthma rhinitis nonsteroidal antiinflammatory druginduced asthma rhinitis see aspirinexacerbated respiratory disease exercise coldair induced asthma see exerciseinduced bronchoconstriction childhood sleep apnea due adenotonsillar hypertrophy see acquired noninflammatory myopathy diet trauma induced combined antihistamine drug therapy also appear useful treating urticarial diseases like members specialized proresolving mediators class eicosanoids possess antiinflammatory inflammation resolving activity randomized controlled trial comparatively stable analog reduced severity eczema study another study inhaled decreased bronchoprovocation patients eoxins newly described stimulate vascular permeability ex vivo human vascular endothelial model small study volunteers production eosinophils isolated severe aspirinintolerant asthmatics greater healthy volunteers mild asthmatic patients findings suggested indicate eoxins proinflammatory actions therefore potentially involved various allergic production eoxins reedsternburg cells also led suggestion involve hodgkins however clinical significance eoxins yet demonstrated like members specialized proresolving mediators class eicosanoids possess antiinflammatory inflammation resolving activity synthetic analog clinical phase iii testing see phases clinical research treatment inflammationbased dry eye syndrome along study clinical trials using analogue treat various ocular conditions also clinical development studies treatment neurodegenerative diseases hearing metabolites eicosapentaenoic acid analogs arachidonic acidderived prostanoid hete lt counterparts include prostanoids eg hydroxyeicosapentaenoic acids eg lts eg many prostanoids hydroxyeicosapentaenoic acids lt shown thought weaker stimulators target cells tissues arachidonic acidderived analogs proposed reduce actions aracidonatederived analogs replacing production weaker eicosapentaenoic acidderived counterparts eoxins described epoxy eicosatrienoic acids presumably epoxy eicosatetraenoic vasodilating actions heart kidney blood vessels well kidneys reabsorption sodium water act reduce blood pressure ischemic injuries heart brain tissues may also act reduce inflammation promote growth metastasis certain tumors promote growth new blood vessels central nervous system regulate release neuropeptide hormones peripheral nervous system inhibit reduce pain reduction aaderived eicosanoids diminished activity alternative products generated fatty acids serve foundation explaining beneficial effects greater intake arachidonic acid aa sits head arachidonic acid cascade twenty eicosanoidmediated signaling paths controlling wide array cellular functions especially regulating inflammation immunity central nervous inflammatory response two groups dietary fatty acids form cascades parallel compete arachidonic acid cascade epa provides important competing cascade dgla provides third less prominent cascade two parallel cascades soften inflammatory effects aa products low dietary intake lessinflammatory fatty acids especially linked several inflammationrelated diseases perhaps mental illnesses us national institutes health national library medicine state level evidence increased dietary improves outcomes hypertriglyceridemia secondary cardiovascular disease prevention hypertension b level evidence good scientific evidence increased dietary primary prevention cardiovascular disease rheumatoid arthritis protection ciclosporin toxicity organ transplant patients also note preliminary evidence showing dietary ease symptoms several psychiatric besides influence eicosanoids dietary polyunsaturated fats modulate immune response three molecular mechanisms alter membrane composition function including composition lipid rafts b change cytokine biosynthesis c directly activate gene action eicosanoids best explored general eicosanoids derived aa promote inflammation epa gla via dgla less inflammatory inactive even antiinflammatory proresolving figure shows synthesis chains along major eicosanoids aa epa dgla dietary gla counter inflammatory effects aas eicosanoids three ways along eicosanoid pathways since antiquity cardinal signs inflammation known calor warmth dolor pain tumor swelling rubor redness eicosanoids involved signs insects sting trigger classic inflammatory response short acting vasoconstrictors released quickly injury site may momentarily turn pale mediates release vasodilators blood vessels engorge injury reddens makes blood vessels permeable plasma leaks connective tissues swell process also loses proinflammatory cytokines cytokines increase activity elevates levels sensitizing pain neurons also potent pyretic agent aspirin block cox pathways stop prostanoid fever heat localized inflammation gynecologist raphael kurzrok pharmacologist charles leib characterized prostaglandin component semen burr burr showed restricting fat animals diets led deficiency disease first described essential fatty von euler identified prostaglandin bergström samuelsson linked observations showed classical eicosanoids derived arachidonic acid earlier considered one essential fatty vane showed aspirin similar drugs inhibit prostaglandin von euler received nobel prize medicine samuelsson vane bergström also received e j corey received chemistry largely synthesis prostaglandins httpsenwikipediaorgwikieicosanoid